Cash Flow Cannara Biotech, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Aug'25
Aug'24
Aug'23
Aug'22
Aug'21
Aug'20
No of Months
12
12
12
12
12
12
Profit Before Tax
18.00
4.00
6.00
2.00
-1.00
-13.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-6.00
-2.00
-6.00
-11.00
-3.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
16.00
6.00
1.00
-7.00
-3.00
-10.00
Cash Flow from Investing Activities
-6.00
-5.00
-9.00
-15.00
-30.00
-8.00
Cash Flow from Financing Activities
-2.00
0.00
0.00
26.00
34.00
0.00
Net Cash Inflow / Outflow
7.00
2.00
-7.00
3.00
0.00
-18.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in CAD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Cannara Biotech, Inc.
Figures in Million
consolidated Cash Flow Results
Change(CAD)
Change(%)
Profit Before Tax
18.096732
-17.6793542287848
35.00
202.36%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-6.304404
-0.760328678572304
-6.00
-729.17%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
16.521513
-10.1062065978881
26.00
263.48%
Cash Flow from Investing Activities
-6.199708
-4.14687371178084
-2.00
-49.50%
Cash Flow from Financing Activities
-2.582176
10.2377229098573
-12.00
-125.22%
Net Cash Inflow / Outflow
7.739629
-4.06193609363402
11.00
290.54%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
-0.0465786938224474
0.00
100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Aug'25
YoY Growth in year ended Aug 2025 is 137.90% vs 346.60% in Aug 2024
Aug'25
Aug'24
Change(%)
Cash Flow from Operating Activities
16.52
6.94
137.90%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
